MP22-19 NEOADJUVANT APALUTAMIDE (ARN-509) AND RADICAL PROSTATECTOMY IN TREATMENT OF INTERMEDIATE TO HIGH RISK PROSTATE CANCER (NEAR)–INITIAL RESULTS OF A PHASE II TRIAL | Zendy

AI Assistant Blog Pricing

MP22-19 NEOADJUVANT APALUTAMIDE (ARN-509) AND RADICAL PROSTATECTOMY IN TREATMENT OF INTERMEDIATE TO HIGH RISK PROSTATE CANCER (NEAR)–INITIAL RESULTS OF A PHASE II TRIAL

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.